Leonardo Nicacio

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens et al. · The Lancet Oncology · 2021 · 394 citations

Medicine, Oncology, Pharmacotherapy +13

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study

Ignace Vergote, Els Van Nieuwenhuysen, Roisin E. O’Cearbhaill et al. · Journal of Clinical Oncology · 2023 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy

Gwyn Bebb, Colum J Smith, Stewart Rorke et al. · Cancer Chemotherapy and Pharmacology · 2010 · 60 citations

Medicine, Oncology, Radiation Oncology +14

Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology Practices

Guru Sonpavde, Menaka Bhor, Daniel Hennessy et al. · Clinical Genitourinary Cancer · 2015 · 48 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Validation of International Classification of Diseases coding for bone metastases in electronic health records using technology-enabled abstraction

Alexander Liede, Rohini K. Hernandez, Maayan Roth et al. · Clinical Epidemiology · 2015 · 36 citations · Full text

Health Professions, Health Informatics, Oncology +15